The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 30, 2014
Filed:
Oct. 01, 2010
Applicants:
Takahiro Ochiya, Tokyo, JP;
Ryou-u Takahashi, Tokyo, JP;
Inventors:
Takahiro Ochiya, Tokyo, JP;
Ryou-u Takahashi, Tokyo, JP;
Assignees:
National Cancer Center, Tokyo, JP;
Asahi Pharma Corporation, Tokyo, JP;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); A61K 31/7088 (2006.01); A61K 31/713 (2006.01); C12N 15/113 (2010.01); C12Q 1/68 (2006.01);
U.S. Cl.
CPC ...
A61K 31/7088 (2013.01); A61K 31/713 (2013.01); C12N 15/113 (2013.01); C12Q 1/6886 (2013.01); C12N 2310/141 (2013.01); C12N 2330/10 (2013.01); C12Q 2600/106 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/178 (2013.01);
Abstract
The present invention provides a therapeutic agent for a tumor, particularly a therapeutic agent for drug-resistant cancer, an agent for suppression or prophylaxis of tumor metastasis, and an agent for suppression or prophylaxis of cancer recurrence, containing a nucleic acid containing miR27b or a nucleotide having a nucleotide sequence having an identity of 70% or more with the nucleotide sequence shown by SEQ ID NO: 1 and having a function equivalent to miR27b.